Cadaveric renal transplantation in patients over 55 years of age with special emphasis on immunosuppressive therapy.
D000368:Aged; D000375:Aging; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002102:Cadaver; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000187:drug effects; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000401:mortality; D011817:Rabbits; D014511:Uremia / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D007166:Immunosuppressive Agents